Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Accumulated Expenses (2016 - 2026)

Bio-Techne has reported Accumulated Expenses over the past 16 years, most recently at $45.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 63.48% year-over-year to $45.0 million; the TTM value through Dec 2025 reached $45.0 million, up 63.48%, while the annual FY2025 figure was $25.7 million, 3.12% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $45.0 million at Bio-Techne, up from $43.6 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $62.0 million in Q2 2022 and troughed at $15.3 million in Q2 2021.
  • A 5-year average of $32.3 million and a median of $30.0 million in 2022 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: soared 346.25% in 2021 and later plummeted 53.78% in 2022.
  • Year by year, Accumulated Expenses stood at $19.0 million in 2021, then fell by 14.28% to $16.3 million in 2022, then increased by 5.41% to $17.2 million in 2023, then skyrocketed by 60.52% to $27.5 million in 2024, then skyrocketed by 63.48% to $45.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for TECH at $45.0 million in Q4 2025, $43.6 million in Q3 2025, and $25.7 million in Q2 2025.